Jac Medical Transcription & Bi is categorized under Formal Writing Services in Cypress, TX and active since 2003.
Jac Medical Transcription & Bi was established in 2003, and today employs 1 to 4, earning $0 to $49.999 per year. This is a Formal Writing Services business, which does work in the B2B market, and is classified as a Formal Writing Services, under code number 561410 by the NAICS.
If you are seeking more information, feel free to contact Irene Garza Pabon at the company’s single location by writing to 15410 Fairfield Falls Way, Cypress, Texas TX 77433 or by phoning (281) 373-0113. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
| Business Name: | Jac Medical Transcription & Bi |
| Contact Person: | Irene Garza Pabon |
| Address: | 15410 Fairfield Falls Way, Cypress, Texas 77433 |
| Phone Number: | (281) 373-0113 |
| Annual Revenue (USD): | $0 to $49.999 |
| Founded: | 2003 |
| Location Type: | Single Location |
| Employee Number: | 1 to 4 |
| Business Type: | B2B (Business to Business) |
| Business Category: | Formal Writing Services |
| SIC Code: | 7338 |
| NAICS Code: | 561410 |
| Share This Business: |
Jac Medical Transcription & Bi was started in 2003 to provide professional Formal Writing Services under the SIC code 7338 and NAICS code 561410. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $0 to $49.999 per annum.
Feel free to contact Irene Garza Pabon for inquiries that concern Jac Medical Transcription & Bi by calling the company number (281) 373-0113, as your correspondence is most welcome. Additionally, the physical location of the single location of Jac Medical Transcription & Bi can be found at the coordinates 29.999101,-95.750291 as well as the street address 15410 Fairfield Falls Way in Cypress, Texas 77433.
For its online presence, you may visit Jac Medical Transcription & Bi’s website at and engage with its social media outlets through on Twitter and on Facebook.